Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment — Massimo Filippi (2014) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment
Shared by
Massimo Filippi
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment
Article
2014
en
Authors
Massimo Filippi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis
Matilde Inglese
,
Béatrice Benedetti
,
Massimo Filippi
Article
2017
The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis
Maria A. Rocca
,
Giancarlo Comi
,
Massimo Filippi
Article
1997
Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials
Frederik Barkhof
,
Massimo Filippi
,
David H. Miller
,
Paul S. Tofts
,
Ludwig Kappos
,
Alan J. Thompson
Article
2009
MR Imaging of Gray Matter Involvement in Multiple Sclerosis: Implications for Understanding Disease Pathophysiology and Monitoring Treatment Efficacy
Massimo Filippi
,
Maria A. Rocca
Book
2007
Neurodegeneration in Multiple Sclerosis
Massimo Filippi
,
Marco Rovaris
,
Giancarlo Comi
Discussion(0)
No comments yet. Be the first to comment.